Jonathan Kish
Advertisement
Articles by Jonathan Kish
19 Real-world Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Talazoparib-Treated Patients With HER2-Negative, Locally Advanced or Metastatic Breast Cancer and Germline BRCA Mutations
ByReshma L. Mahtani, DO ,Jasmina Ivanova,Angelica Falkenstein,Alexander Niyazov,Joanne C. Ryan,Jonathan Kish,Ajeet Gajra,Kristin M. Zimmerman Savill
Published: | Updated:
Advertisement
Latest Updated Articles
19 Real-world Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Talazoparib-Treated Patients With HER2-Negative, Locally Advanced or Metastatic Breast Cancer and Germline BRCA MutationsPublished: April 18th 2022 | Updated: April 19th 2022
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
2
FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma
3
Where Does KEYNOTE-B96 Regimen Fit in Pretreated Ovarian Cancer?
4
Encorafenib/Cetuximab Plus FOLFIRI Improves PFS in BRAF V600E-Mutant mCRC
5